Richard Morgan

Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY.

Amphion Capital Management LLC (Amphion Capital) is a venture capital firm subsidiary of Amphion Innovations Plc founded in 1995 by Richard Morgan and Robert Bertoldi. The firm is headquartered in New York.

WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY.

Amphion Innovations Plc engages in creating, building, operating, and financing life science and technology companies in partnership with corporations, governments, universities, and entrepreneurs seeking to commercialize their intellectual property. The firm also provides advisory and consultancy services to these companies. It operates through the following segments: Advisory Services, Investing Activities, and Intellectual Property. Its services include direct management, strategic planning, intellectual property planning and strategy, capital raising, recruiting, business development, and other advisory services in areas such as marketing, administration, and capital markets. The company was founded on June 7, 2005 and is headquartered in Stamford, CT.

Vennworks LLC provides investment services. The private company is based in New York, NY. The company was founded by Robert Joseph Bertoldi, Richard Cecil Eversfield Morgan.

Amphion Capital Partners LLC used to create, develop and operate healthcare and technology companies in partnership with corporations, universities and others seeking to profitably commercialize intellectual property. Focusing on long-term growth and profitability, the company's management team had collectively created and developed more than 50 technology-driven companies in the information technology, physical and life sciences industries. In the physical and life sciences industries, these companies include Celgene, Medisense, Quidel, and SEQUUS. The company was headquartered in New York, NY.

Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom.

ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY.

PrivateMarkets, Inc. provides bilateral electronic structured transaction solutions for energy commodities. It allows traders to electronically create a private marketplace of known counterparties and structure each trade to match their specific needs. The company was founded by Kenneth A. Lord in 2007 and is headquartered in Boxborough, MA.

DataTern, Inc. commercializes selected intellectual property technology opportunities which originate from Amphion’s Partner Companies. Its two patents (the ‘502 and ‘402 patents) are directed to how object-oriented software applications access data stored in relational databases. The company is headquartered in New York, NY.

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.